People · Operator
Named in public records as an officer, director or promoter · active 2016–2019 · Medical Devices, Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Acuamark Diagnostics, Inc. | — | Medical Devices | Series A | $20.3M | $25.6M | 2019 |
| NX Development Corp. | — | Biotechnology | Seed | $2.5M | $31.1M | 2016 |
| nQ Medical, Inc. | — | Healthtech | Seed | $1.5M | $40.2M | 2018 |
Gregory Murdock at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gregory Murdock on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Saunders | 1 | 18 |
| Joseph Smith | 1 | 7 |
| Brian Brohman | 1 | 4 |
| Cedric Francois | 1 | 4 |
| Brian Carr | 1 | 3 |
| Fred Mermelstein | 1 | 3 |
| Alan Ezrin | 1 | 3 |
| William Gedale | 1 | 2 |
| Michael Hanbury | 1 | 2 |
| Claudio Del Vecchio | 1 | 2 |
| Michael Gargano | 1 | 2 |
| Alan M. Ezrin | 1 | 2 |
| David Weavil | 1 | 1 |
| Vanja Vuletic | 1 | 1 |
| Giulia Kennedy | 1 | 1 |
| Howard Johnson | 1 | 1 |
| Mark Pascarella | 1 | 1 |
| Richie Bavasso | 1 | 1 |
| Bernard Peperstraete | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.